<VariationArchive VariationID="16498" VariationName="NM_000043.6(FAS):c.334+2dup" VariationType="Duplication" Accession="VCV000016498" Version="2" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-02-20" DateCreated="2015-05-18" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="31537" VariationID="16498">
      <GeneList>
        <Gene Symbol="FAS" FullName="Fas cell surface death receptor" GeneID="355" HGNC_ID="HGNC:11920" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>10q23.31</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="10" Accession="NC_000010.11" start="88964050" stop="89017059" display_start="88964050" display_stop="89017059" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="10" Accession="NC_000010.10" start="90750287" stop="90775541" display_start="90750287" display_stop="90775541" Strand="+" />
          </Location>
          <OMIM>134637</OMIM>
          <Haploinsufficiency last_evaluated="2022-02-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FAS">Little evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2022-02-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FAS">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000043.6(FAS):c.334+2dup</Name>
      <CanonicalSPDI>NC_000010.11:89007838:T:TT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>10q23.31</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="10" Accession="NC_000010.11" start="89007838" stop="89007839" display_start="89007838" display_stop="89007839" variantLength="1" positionVCF="89007838" referenceAlleleVCF="G" alternateAlleleVCF="GT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="10" Accession="NC_000010.10" start="90767595" stop="90767596" display_start="90767595" display_stop="90767596" variantLength="1" positionVCF="90767595" referenceAlleleVCF="G" alternateAlleleVCF="GT" />
      </Location>
      <OtherNameList>
        <Name>EX3DEL</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_134t1" sequenceAccession="LRG_134t1" change="c.334+2dup">
            <Expression>LRG_134t1:c.334+2dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_134" sequenceAccession="LRG_134" change="g.22309dup">
            <Expression>LRG_134:g.22309dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000010.10" sequenceAccession="NC_000010" sequenceVersion="10" change="g.90767596dup" Assembly="GRCh37">
            <Expression>NC_000010.10:g.90767596dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000010.11" sequenceAccession="NC_000010" sequenceVersion="11" change="g.89007839dup" Assembly="GRCh38">
            <Expression>NC_000010.11:g.89007839dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009089.2" sequenceAccession="NG_009089" sequenceVersion="2" change="g.22309dup">
            <Expression>NG_009089.2:g.22309dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000043.6" sequenceAccession="NM_000043" sequenceVersion="6" change="c.334+2dup" MANESelect="true">
            <Expression>NM_000043.6:c.334+2dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_152872.4" sequenceAccession="NM_152872" sequenceVersion="4" change="c.334+2dup">
            <Expression>NM_152872.4:c.334+2dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001320619.2" sequenceAccession="NM_001320619" sequenceVersion="2" change="c.334+2dup">
            <Expression>NM_001320619.2:c.334+2dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_152871.4" sequenceAccession="NM_152871" sequenceVersion="4" change="c.334+2dup">
            <Expression>NM_152871.4:c.334+2dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA212968" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="134637.0002" DB="OMIM" />
        <XRef Type="rs" ID="606231362" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff reviewed the sequence information reported in PubMed 7540117 to determine the location of this allele on the current reference sequence. </Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000043.6(FAS):c.334+2dup AND Autoimmune lymphoproliferative syndrome, type 1a" Accession="RCV000017962" Version="25">
        <ClassifiedConditionList TraitSetID="5422">
          <ClassifiedCondition DB="MedGen" ID="C1866119">Autoimmune lymphoproliferative syndrome, type 1a</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1995-06-16" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000043.6(FAS):c.334+2dup AND Autoimmune lymphoproliferative syndrome type 1" Accession="RCV003517125" Version="1">
        <ClassifiedConditionList TraitSetID="6277">
          <ClassifiedCondition DB="MedGen" ID="C1328840">Autoimmune lymphoproliferative syndrome type 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-05-09" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-05-09" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2015-05-18" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">17576681</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">7540117</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9536098</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="6277" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="369" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Autoimmune lymphoproliferative syndrome type 1</ElementValue>
                <XRef ID="MONDO:0011158" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE I, AUTOSOMAL DOMINANT</ElementValue>
                <XRef Type="MIM" ID="601859" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Autoimmune lymphoproliferative syndrome type 1, autosomal dominant</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">ALPS</ElementValue>
                <XRef Type="MIM" ID="601859" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Autoimmune lymphoproliferative syndrome (ALPS), caused by defective lymphocyte homeostasis, is characterized by the following: Non-malignant lymphoproliferation (lymphadenopathy, hepatosplenomegaly with or without hypersplenism) that often improves with age. Autoimmune disease, mostly directed toward blood cells. Lifelong increased risk for both Hodgkin and non-Hodgkin lymphoma. In ALPS-FAS (the most common and best-characterized type of ALPS, associated with heterozygous germline pathogenic variants in FAS), non-malignant lymphoproliferation typically manifests in the first years of life, inexplicably waxes and wanes, and then often decreases without treatment in the second decade of life; in many affected individuals, however, neither splenomegaly nor the overall expansion of lymphocyte subsets in peripheral blood decreases. Although autoimmunity is often not present at the time of diagnosis or at the time of the most extensive lymphoproliferation, autoantibodies can be detected before autoimmune disease manifests clinically. In ALPS-FAS caused by homozygous or compound heterozygous (biallelic) pathogenic variants in FAS, severe lymphoproliferation occurs before, at, or shortly after birth, and usually results in death at an early age. ALPS-sFAS, resulting from somatic FAS pathogenic variants in selected cell populations, notably the alpha/beta double-negative T cells (a/ß-DNT cells), appears to be similar to ALPS-FAS resulting from heterozygous germline pathogenic variants in FAS, although lower incidence of splenectomy and lower lymphocyte counts have been reported in ALPS-sFAS and no cases of lymphoma have yet been published.</Attribute>
                <XRef ID="NBK1108" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301287</ID>
                <ID Source="BookShelf">NBK1108</ID>
              </Citation>
              <Citation Type="general" Abbrev="NIH, 2009">
                <ID Source="pmc">2953894</ID>
              </Citation>
              <XRef ID="3261" DB="Orphanet" />
              <XRef ID="C1328840" DB="MedGen" />
              <XRef ID="MONDO:0011158" DB="MONDO" />
              <XRef Type="MIM" ID="601859" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="5422" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="12625" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IA, AUTOSOMAL RECESSIVE</ElementValue>
                <XRef Type="Allelic variant" ID="134637.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="134637.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="134637.0013" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Autoimmune lymphoproliferative syndrome, type 1a</ElementValue>
                <XRef ID="Autoimmune+lymphoproliferative+syndrome%2C+type+1a/7776" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">ALPS1A</ElementValue>
                <XRef ID="601859" DB="OMIM" />
              </Symbol>
              <XRef ID="C1866119" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="38241" SubmissionDate="2015-05-15" DateLastUpdated="2015-05-18" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="134637.0002_AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IA" title="FAS, EX3DEL_AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IA" />
        <ClinVarAccession Accession="SCV000038241" DateUpdated="2015-05-18" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1995-06-16">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a patient with autoimmune lymphoproliferative syndrome type IA (ALPS1A; 601859), Fisher et al. (1995) found in-frame deletion of exon 3 of the FAS gene, resulting from a 1-bp insertion in the 5-prime splice site of intron 3 and leading to a change in the extracellular domain of the protein. Although the patient's mother, who was heterozygous for the same mutation, had no clinical abnormalities, in vitro analysis showed impaired T-lymphocyte apoptosis. Fisher et al. (1995) concluded that the exon 3 deletion had a dominant interfering effect, but also noted that genetic modifiers must be involved.</Attribute>
              <Citation>
                <ID Source="PubMed">7540117</ID>
              </Citation>
              <XRef DB="OMIM" ID="601859" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FAS" />
          </GeneList>
          <Name>FAS, EX3DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">EX3DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="134637.0002" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IA</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7980615" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2024-02-14">
        <ClinVarSubmissionID localKey="4886668|MedGen:C1328840" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004295328" DateUpdated="2024-02-14" DateCreated="2024-02-14" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-05-09">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">17576681</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9536098</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">7540117</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">7540117</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Studies have shown that this variant is associated with altered splicing resulting in multiple RNA products (PMID: 7540117). ClinVar contains an entry for this variant (Variation ID: 16498). This variant has been observed in individual(s) with autoimmune lymphoproliferative syndrome (PMID: 7540117; Invitae). This variant is not present in population databases (gnomAD no frequency). This sequence change falls in intron 3 of the FAS gene. It does not directly change the encoded amino acid sequence of the FAS protein. It affects a nucleotide within the consensus splice site.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FAS" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000010.10:g.90767595_90767596insT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1328840" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="38241" TraitType="Disease" MappingType="Name" MappingValue="AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IA" MappingRef="Preferred">
        <MedGen CUI="C1866119" Name="Autoimmune lymphoproliferative syndrome, type 1a" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7980615" TraitType="Disease" MappingType="XRef" MappingValue="C1328840" MappingRef="MedGen">
        <MedGen CUI="C1328840" Name="Autoimmune lymphoproliferative syndrome type 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

